- SITE CHAIR, CARDIOLOGY, MOUNT SINAI BETH ISRAEL
- SENIOR FACULTY Medicine, Cardiology
- SENIOR FACULTY Cardiovascular Surgery
MD, Temple University
Residency, Internal Medicine
Massachusetts General Hospital
Fellowship, Cardiovascular Dis
Peter Bent Brigham Hospital
Dr. Blase A. Carabello is Chair of Cardiology at Mount Sinai Beth Israel, and also serves as Medical Director of the Heart Valve Center at The Mount Sinai Hospital.
Dr. Carabello is an internationally recognized expert in the field of valvular heart disease. He specializes in the care of patients who have complex valvular heart disease, and in the practice of general internal medicine. Prior to joining Mount Sinai, Dr. Carabello served as Chief of Cardiology at the Texas Heart Institute at St. Luke’s Episcopal Health System, and Director of its Center for Heart Valve Disease. He was also Vice Chair of the Department of Medicine at Baylor College of Medicine and Chief of Medicine at the Michael E. DeBakey Veterans Administration Medical Center.
As a leading researcher in valvular heart disease, Dr. Carabello has published more than 250 peer-reviewed research studies and 200 book chapters and editorials. He has co-authored the American Heart Association/American College of Cardiology Guidelines for the Treatment of Valvular Disease from 1998-2014. In 2009, he was honored by the American College of Cardiology as a recipient of its prestigious Distinguished Scientist Award. Dr. Carabello is past President of both the Society for Heart Valve Disease and the Association of University Cardiologists, past Vice President of the Heart Valve Society of America, and a member of the American Society for Clinical Investigation.
After attending Gettysburg College, Dr. Carabello graduated cum laude from Temple University School of Medicine. At Harvard Medical School, he received his residency training in internal medicine at Massachusetts General Hospital, and completed his cardiology fellowship at Brigham and Women’s Hospital.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Carabello did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.